Skip to Content
Merck
CN

Headaches as a presenting symptom of linear morphea en coup de sabre.

Pediatrics (2014-11-19)
Ingrid Polcari, Amanda Moon, Erin F Mathes, Elaine S Gilmore, Amy S Paller
ABSTRACT

Linear morphea en coup de sabre (ECDS) is a form of localized scleroderma that predominantly affects the pediatric population, with a median age of 10 years at presentation. The existence of neurologic findings in association with ECDS has been well described in the literature. Here we describe 4 patients with ECDS who presented with headaches, which were typical migraines in 3 of the patients. The headaches preceded the onset of cutaneous findings by at least 6 months. Our patients' cases emphasize both the importance of recognizing headaches as a harbinger of ECDS and the necessity of performing thorough cutaneous examination in patients with unexplained headaches or other neurologic disease.

MATERIALS
Product Number
Brand
Product Description

Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Methotrexate, meets USP testing specifications
Sigma-Aldrich
Methotrexate hydrate, powder, BioReagent, suitable for cell culture, ≥98% (HPLC)
Sigma-Aldrich
Methotrexate hydrate, ≥99.0% (sum of enantiomers, HPLC)
Supelco
Methotrexate solution, 1.0 mg/mL in methanol with 0.1N NaOH, ampule of 1 mL, certified reference material, Cerilliant®
SAFC
Methotrexate
Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard
Methotrexate, European Pharmacopoeia (EP) Reference Standard
Supelco
Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Methotrexate hydrate, ≥98% (HPLC), powder